# The Effect of Escitalopram in PCOS

> **NCT05840692** · PHASE4 · COMPLETED · sponsor: **Odense University Hospital** · enrollment: 40 (actual)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** Escitalopram 20 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05840692
- **Lead sponsor:** Odense University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05840692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05840692, "The Effect of Escitalopram in PCOS". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05840692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*